Mon, June 5, 2023

Aydin Huseynov Maintained (ATHE) at Strong Buy with Decreased Target to $10 on, Jun 5th, 2023

Aydin Huseynov of Ladenburg Thalmann, Maintained "Alterity Therapeutics Limited" (ATHE) at Strong Buy with Decreased Target from $20 to $10 on, Jun 5th, 2023.

Aydin, nor any peers, have made any analyst calls on ATHE in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30